Regencell Historical Cash Flow
| RGC Stock | USD 5.49 0.04 0.73% |
Analysis of Regencell Bioscience cash flow over time is an excellent tool to project Regencell Bioscience future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 708.3 K or Dividends Paid of 191.8 M as it is a great indicator of Regencell Bioscience ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Regencell Bioscience latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Regencell Bioscience is a good buy for the upcoming year.
Regencell |
About Regencell Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Regencell balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Regencell's non-liquid assets can be easily converted into cash.
Regencell Bioscience Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Regencell Bioscience's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Regencell Bioscience current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regencell Bioscience Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At present, Regencell Bioscience's Total Cash From Financing Activities is projected to increase significantly based on the last few years of reporting. The current year's Investments is expected to grow to about 5.5 M, whereas Change To Inventory is projected to grow to (1.1 M).
Regencell Bioscience cash flow statement Correlations
Click cells to compare fundamentals
Regencell Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Regencell Bioscience cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 143.7K | (327.6K) | 6.4M | (4.9M) | 1.4M | 1.3M | |
| Free Cash Flow | (844.4K) | (767.3K) | (6.0M) | (5.0M) | (4.0M) | (3.8M) | |
| Change In Working Capital | 76.3K | 553.0K | (1.0M) | (508.9K) | (585.4K) | (556.1K) | |
| Begin Period Cash Flow | 243.3K | 387.0K | 59.4K | 6.4M | 1.6M | 1.5M | |
| Other Cashflows From Financing Activities | 988.1K | (172.3K) | (268.0K) | 134.9K | 102.3K | 97.2K | |
| Total Cash From Operating Activities | (726.6K) | (767.3K) | (5.3M) | (5.0M) | (4.0M) | (3.8M) | |
| Net Income | (812.4K) | (1.3M) | (7.6M) | (6.1M) | (4.4M) | (4.1M) | |
| Total Cash From Financing Activities | 988.1K | 439.7K | 22.4M | 134.9K | 102.3K | 107.4K | |
| End Period Cash Flow | 387.0K | 59.4K | 6.4M | 1.6M | 3.0M | 2.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Regencell Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regencell Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regencell Bioscience Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regencell Bioscience Holdings Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regencell Bioscience Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.33) | Return On Assets (0.28) | Return On Equity (0.43) |
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.